61 – 70 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study
(
- Contribution to journal › Article
-
Mark
Chronic Inflammation and Atherosclerosis
2015) p.157-167(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2014
-
Mark
Treatment with betablockers is associated with higher grey-scale median in carotid plaques
(
- Contribution to journal › Article
-
Mark
Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.
(
- Contribution to journal › Article
-
Mark
Impaired Fibrous Repair: A Possible Contributor to Atherosclerotic Plaque Vulnerability in Patients With Type II Diabetes.
(
- Contribution to journal › Article
-
Mark
Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques.
(
- Contribution to journal › Article
- 2013
-
Mark
Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques.
(
- Contribution to journal › Article
-
Mark
Potential Influence of Diet on Bomb-Pulse Dating of Human Plaque Samples
(
- Contribution to journal › Article
- 2012
-
Mark
Evidence Supporting a Key Role of Lp-PLA2-Generated Lysophosphatidylcholine in Human Atherosclerotic Plaque Inflammation.
(
- Contribution to journal › Article
- 2011
-
Mark
Activator protein-1 in carotid plaques is related to cerebrovascular symptoms and cholesteryl ester content.
(
- Contribution to journal › Article